Hyperuricemia and its related diseases: mechanisms and advances in therapy

L Du, Y Zong, H Li, Q Wang, L Xie, B Yang… - … and Targeted Therapy, 2024 - nature.com
Hyperuricemia, characterized by elevated levels of serum uric acid (SUA), is linked to a
spectrum of commodities such as gout, cardiovascular diseases, renal disorders, metabolic …

Role of diet in hyperuricemia and gout

A Danve, ST Sehra, T Neogi - Best practice & research Clinical …, 2021 - Elsevier
Background Gout is the most common form of inflammatory arthritis, affecting 41 million
adults worldwide. The global burden of gout has been increasing over the last three …

Management of hyperuricemia in patients with chronic kidney disease: a focus on renal protection

JT Kielstein, R Pontremoli, M Burnier - Current Hypertension Reports, 2020 - Springer
Abstract Purpose of Review In chronic kidney disease (CKD), plasma uric acid levels are
increased because of the decrease in glomerular filtration rate. However, in addition to CKD …

Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA‐HF

K McDowell, P Welsh, KF Docherty… - European journal of …, 2022 - Wiley Online Library
Aims Blood uric acid (UA) levels are frequently elevated in patients with heart failure and
reduced ejection fraction (HFrEF), may lead to gout and are associated with worse …

Update in uric acid, hypertension, and cardiovascular diseases

M Kuwabara, T Kodama, R Ae, M Kanbay… - Hypertension …, 2023 - nature.com
A direct relationship between serum uric acid levels and hypertension, cardiovascular, renal
and metabolic diseases has been reported in many basic and epidemiological studies …

Management of hyperuricemia in asymptomatic patients: a critical appraisal

A Brucato, F Cianci, C Carnovale - European Journal of Internal Medicine, 2020 - Elsevier
While there is consensus on starting urate-lowering therapy (ULT) in cases of symptomatic
hyperuricemia, the frequent condition of asymptomatic hyperuricemia (AH) remains a …

One year in review 2020: gout

L Punzi, A Scanu, P Galozzi, R Luisetto… - Clinical and …, 2020 - boa.unimib.it
Gout is the most prevalent form of inflammatory arthritis, with a strong impact on individual
health and healthcare systems. This article reviews clinical and experimental evidences …

Uric acid and hypertension: prognostic role and guide for treatment

F Piani, AFG Cicero, C Borghi - Journal of clinical medicine, 2021 - mdpi.com
The relationship between serum uric acid (SUA) and hypertension has been a subject of
increasing interest since the 1870 discovery by Frederick Akbar Mahomed. Several …

Serum uric acid lowering and effects of sodium‐glucose cotransporter‐2 inhibitors on gout: A meta‐analysis and meta‐regression of randomized controlled trials

M Banerjee, R Pal, I Maisnam… - Diabetes, Obesity …, 2023 - Wiley Online Library
Aims To pool the effects of sodium‐glucose cotransporter‐2 (SGLT2) inhibitors on gout and
to investigate the association of these effects with baseline serum uric acid (SUA), SUA …

Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk: 2021 update

C Borghi, J Domienik-Karłowicz, A Tykarski… - Cardiology …, 2021 - journals.viamedica.pl
Uric acid (UA) is the end product of purine metabolism, and its concentration in blood can
increase in humans, great apes, and dalmatian dogs as a consequence of a genetic …